Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Funding Crisis Hits China Life Sciences Industry, But China Is Faring Better Than The West

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - Pitching her company to a group of potential investors in Hong Kong during the ChinaBio Investor Forum, Carrie Yuen painted a glowing picture of the potential of the Chinese market for medical devices

You may also be interested in...



Shanghai Issues New Policy To Draw Venture Capitalists and Private Equity Funds To China

SHANGHAI - Shanghai's municipal government released a new policy June 10 to allow foreign venture capitalists and private equity firms to establish firms in the Pudong district

Shanghai Issues New Policy To Draw Venture Capitalists and Private Equity Funds To China

SHANGHAI - Shanghai's municipal government released a new policy June 10 to allow foreign venture capitalists and private equity firms to establish firms in the Pudong district

Lack Of Funding and Political Will Hinders Hong Kong’s Untapped Drug Discovery Research – ChinaBio Investor Forum

HONG KONG - Generally overshadowed by Singapore or Taiwan as a pharmaceutical and biotech center in Southeast Asia, Hong Kong has deep reserves of untapped knowledge and intellectual property

Latest Headlines
See All
UsernamePublicRestriction

Register

SC070878

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel